A short teaser from a Medical Update interview on how much of the weight lost on GLP-1 drugs is muscle. The full talk is on their podcast.
Recap by typeshit. Post by @medicalupdateonline on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short social post from CPOHealth on how GLP-1 drugs lower appetite and blood sugar, with a reminder that side effects come with them.
She argues the FDA held its remand decision until after oral arguments so the court wouldn't have it in hand. Few other details are given.
Loading…